NeutralLOW severityHealthcare & Pharma2d ago

Ginkgo Bioworks director Christian O. Henry sells $35,405 in shares

Ginkgo Bioworks director Christian O. Henry sells $35,405 in shares — $DNA one-month chart
$DNA daily closes over the past month · Wook of Wall Street artwork from market data

At a glance

WOOK’s read

Ginkgo Bioworks shares fell 6.06% to $9.61, near the lower end of its 52-week range. The stock is trading at 33% of its range, slightly below the midpoint, with minimal recent coverage that’s mostly neutral. The Health Care sector shows calm, but attention to $DNA has spiked recently, mostly in the last week.

Written by Wook AI Nov 15, 10:31 AM ET from this page’s own figures at that time — not from the article — with every number checked against them. Not investment advice.

WOOKAI ASSISTANTREADY
WOOK AIASK ANYTHING · NEVER ADVISES

Ask about DNA. Get explanations, comparisons and calculations with the source lookups shown.

Risk check · ginkgo bioworksEvent risk Low

Nothing reported about ginkgo bioworks across key-person, legal, regulatory, security, operational or financial-integrity risk in three weeks of coverage and 30 days of SEC filings.

From here · last month’s volatility 153% a year
Now $8.32Week $6.53–$10.11 (±21.5%)Month $4.65–$11.99 (±44.1%)
Ask Wook AI

Ranges are one standard deviation of volatility around the latest close — about 1 week in 3 moves further. Not a forecast or investment advice.

Wook analysis

What it means

Key points
  • What to watch: Christian O. Henry's $35,405 share sale is a concrete detail—track it against recent patterns before assuming it signals a shift.
  • How the stock is trading: $DNA +1.53% in the latest session.
  • Timing: It was published over the weekend. The change shown is Friday's, and Monday is the first session that could react. Market holidays are not detected.
Amount$35,405

Where the stock stands

Ginkgo Bioworks ($DNA) rose 1.53% to $8.63 in the latest session. Over the past month it is down 17.4%. That leaves it 53% below its 52-week high of $18.22 and 61% above its low of $5.37. It has been a volatile year: the high was 3.4 times the low, so moves this size are not unusual for it.

What the filings say

In its latest report (10-Q, filed Nov 9, 2026), $DNA lost $41.0M over the quarter to Sep 30, 2026 on revenue of $27.7M (+37.5% QoQ). Operations used $119.3M of cash over the nine months to Sep 30, 2026 — about $13.3M a month — against $84.5M in cash on Sep 30, 2026. At that pace the cash covers about 6 months, which is why financing, asset sales or restructuring tend to come up for companies in this position. Total liabilities were $551.8M against $84.5M of cash on Sep 30, 2026. Its most recent filings before this story: 10-Q on Nov 9, 2026, 8-K on Nov 5, 2026, 8-K on Oct 29, 2026. Figures are as filed with the SEC; the $DNA page has the full statements.

How much coverage it is getting

This is the only story on Ginkgo Bioworks in Wook's last 30 days of coverage, so there is no recent run to compare it with.

The bigger picture

In healthcare, news often hinges on regulatory decisions, trial results, and pricing changes—each can tilt a drugmaker’s fate or shift the entire sector. Health Care reads calm on Wook's supply-chain scanner today, with no unusual stress in the filings and disclosures it watches.

What to watch next

Check $DNA’s SEC filings for direct insights. Wook AI can help compare its current price to past highs or analyze how this week’s coverage stacks up against previous reports.

Discussion

No one has weighed in yet. Start the discussion on this story.

What happened after this published

Investing.com published this on November 15, 2026. $DNA has moved -10.75% ($9.67 to $8.63). Measured from the first print available after publication, against the latest available quote. This comparison does not isolate the story's effect.

Headline and link are attributed to Investing.com. Wook of Wall Street is an independent research tool and is not affiliated with Investing.com. Nothing here is financial advice or a recommendation — research and educational content only.

Choose what Wook may measure. Essential sign-in and security cookies stay on.

Read the privacy policy